Cargando…

Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment

Polycystic liver disease (PLD) is a clinical condition characterized by the presence of more than 10 cysts in the liver. It is a rare disease Of genetic etiology that presents as an isolated disease or assoc\iated with polycystic kidney disease. Ductal plate malformation, ciliary dysfunction, and ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Norcia, Luiz Fernando, Watanabe, Erika Mayumi, Hamamoto Filho, Pedro Tadao, Hasimoto, Claudia Nishida, Pelafsky, Leonardo, de Oliveira, Walmar Kerche, Sassaki, Ligia Yukie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528914/
https://www.ncbi.nlm.nih.gov/pubmed/36200122
http://dx.doi.org/10.2147/HMER.S377530
_version_ 1784801391722627072
author Norcia, Luiz Fernando
Watanabe, Erika Mayumi
Hamamoto Filho, Pedro Tadao
Hasimoto, Claudia Nishida
Pelafsky, Leonardo
de Oliveira, Walmar Kerche
Sassaki, Ligia Yukie
author_facet Norcia, Luiz Fernando
Watanabe, Erika Mayumi
Hamamoto Filho, Pedro Tadao
Hasimoto, Claudia Nishida
Pelafsky, Leonardo
de Oliveira, Walmar Kerche
Sassaki, Ligia Yukie
author_sort Norcia, Luiz Fernando
collection PubMed
description Polycystic liver disease (PLD) is a clinical condition characterized by the presence of more than 10 cysts in the liver. It is a rare disease Of genetic etiology that presents as an isolated disease or assoc\iated with polycystic kidney disease. Ductal plate malformation, ciliary dysfunction, and changes in cell signaling are the main factors involved in its pathogenesis. Most patients with PLD are asymptomatic, but in 2–5% of cases the disease has disabling symptoms and a significant reduction in quality of life. The diagnosis is based on family history of hepatic and/or renal polycystic disease, clinical manifestations, patient age, and polycystic liver phenotype shown on imaging examinations. PLD treatment has evolved considerably in the last decades. Somatostatin analogues hold promise in controlling disease progression, but liver transplantation remains a unique curative treatment modality.
format Online
Article
Text
id pubmed-9528914
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-95289142022-10-04 Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment Norcia, Luiz Fernando Watanabe, Erika Mayumi Hamamoto Filho, Pedro Tadao Hasimoto, Claudia Nishida Pelafsky, Leonardo de Oliveira, Walmar Kerche Sassaki, Ligia Yukie Hepat Med Review Polycystic liver disease (PLD) is a clinical condition characterized by the presence of more than 10 cysts in the liver. It is a rare disease Of genetic etiology that presents as an isolated disease or assoc\iated with polycystic kidney disease. Ductal plate malformation, ciliary dysfunction, and changes in cell signaling are the main factors involved in its pathogenesis. Most patients with PLD are asymptomatic, but in 2–5% of cases the disease has disabling symptoms and a significant reduction in quality of life. The diagnosis is based on family history of hepatic and/or renal polycystic disease, clinical manifestations, patient age, and polycystic liver phenotype shown on imaging examinations. PLD treatment has evolved considerably in the last decades. Somatostatin analogues hold promise in controlling disease progression, but liver transplantation remains a unique curative treatment modality. Dove 2022-09-29 /pmc/articles/PMC9528914/ /pubmed/36200122 http://dx.doi.org/10.2147/HMER.S377530 Text en © 2022 Norcia et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Norcia, Luiz Fernando
Watanabe, Erika Mayumi
Hamamoto Filho, Pedro Tadao
Hasimoto, Claudia Nishida
Pelafsky, Leonardo
de Oliveira, Walmar Kerche
Sassaki, Ligia Yukie
Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
title Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
title_full Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
title_fullStr Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
title_full_unstemmed Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
title_short Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
title_sort polycystic liver disease: pathophysiology, diagnosis and treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528914/
https://www.ncbi.nlm.nih.gov/pubmed/36200122
http://dx.doi.org/10.2147/HMER.S377530
work_keys_str_mv AT norcialuizfernando polycysticliverdiseasepathophysiologydiagnosisandtreatment
AT watanabeerikamayumi polycysticliverdiseasepathophysiologydiagnosisandtreatment
AT hamamotofilhopedrotadao polycysticliverdiseasepathophysiologydiagnosisandtreatment
AT hasimotoclaudianishida polycysticliverdiseasepathophysiologydiagnosisandtreatment
AT pelafskyleonardo polycysticliverdiseasepathophysiologydiagnosisandtreatment
AT deoliveirawalmarkerche polycysticliverdiseasepathophysiologydiagnosisandtreatment
AT sassakiligiayukie polycysticliverdiseasepathophysiologydiagnosisandtreatment